Expert Interview
A Third View: Understanding the progression of antibiotic resistance, the development of new antibiotics, and the potential of the PASTEUR Act which has been introduced to Congress.
Ticker(s): IBB-
Very comfortable speaking about antibiotic resistance frequently treats patient with bacterial infections and 10-15% of those patient have some type of antibiotic resistance
-
Hospitalist with Scripps Hospital and the University of Arizona
What hurdles do you see companies running into in developing new antibiotics?
Added By: max_adminOn a scale of 1-10 how excited are you regarding the PASTEUR act?
Added By: max_adminWhat is the current state of treatments with new resistance developing?
Added By: max_adminDo you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
